SEC Form D private-offering filing

Rani Therapeutics Holdings, Inc.

A new SEC Form D private-offering notice from San Jose, CA, a $60,255,052 filer-stated offering target in Biotech. The source filing is one click away.

Clinical stage biotherapeutics company developing the RaniPill robotic capsule for oral delivery of biologic drugs, publicly traded on Nasdaq as RANI.

Filed 2025-11-10Filed to raise $60,255,052First money in 2025-10-23Raised so far $60,255,052HQ (as filed) San Jose, CASector Biotech Stage (inferred) GrowthCall status Call-ready
Source linked the Form D on EDGAR↗Website verified ranitherapeutics.com↗Named in the filing 9 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.